Table of Contents
The generic injectables sector exceeds US$11.2 billion and numerous high-value injectable products will face patent expiry in major markets over the next decade. This critical new report evaluates the markets, players and products in detail. As companies seek new ways to gain a competitive edge in maturing generics markets, injectables have become increasingly desirable to the major players. Companies like Teva, Sandoz, Mylan, Hospira and ...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Robyn
+1 718 213 4904
TechNavio's analysts forecast the Global Hyaluronic Acid market to grow at a CAGR of 9.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in aging ...
... September 2012) why now Office of generic drugs (ogd)/fda has been significantly under resourced for more than a decade the pharmaceutical industry has globalized requiring fda oversight ...
... Hale & tempest how to provide affordable medicines in today S competitive global market dr. Brian w tempest www.Briantempest.Com world generic medicines congress london ...
Reportlinker.com © Copyright 2013. All rights reserved.